Politicians

New commissioner appointments to the Canada Employment Insurance Commission

Retrieved on: 
Wednesday, July 14, 2021

GATINEAU, QC, July 14, 2021 /CNW/ - The Canada Employment Insurance Commission (CEIC) plays a leadership role, with Employment and Social Development Canada (ESDC), in overseeing the Employment Insurance (EI) program.

Key Points: 
  • GATINEAU, QC, July 14, 2021 /CNW/ - The Canada Employment Insurance Commission (CEIC) plays a leadership role, with Employment and Social Development Canada (ESDC), in overseeing the Employment Insurance (EI) program.
  • Today, the Minister of Employment, Workforce Development and Disability Inclusion, Carla Qualtrough, announced the appointment of Nancy Healey as the new Commissioner for Employers and the reappointment of Pierre Lalibert as the Commissioner for Workers at the CEIC.
  • The Commissioner for Employers and the Commissioner for Workers represent the interests of employers and workers, respectively.
  • The Commissioner for Workers and the Commissioner for Employers are appointed by the Governor in Council.

SJI to Host Second Quarter 2021 Earnings Conference Call

Retrieved on: 
Wednesday, July 14, 2021

FOLSOM, NJ, July 14, 2021 SJI (NYSE: SJI) President and Chief Executive Officer, Michael J. Renna, along with key members of the companys Senior Management team, will host an open conference call and webcast to review the companys second quarter 2021 financial results on Thursday, August 5, 2021 at 11:00 A.M.

Key Points: 
  • FOLSOM, NJ, July 14, 2021 SJI (NYSE: SJI) President and Chief Executive Officer, Michael J. Renna, along with key members of the companys Senior Management team, will host an open conference call and webcast to review the companys second quarter 2021 financial results on Thursday, August 5, 2021 at 11:00 A.M.
  • SJI will release these results on Wednesday, August 4, 2021, following the market close.
  • To listen to the conference call, please dial either the toll-free or international number provided below and enter the passcode.
  • You may also listen to the call on the SJI website at www.sjindustries.com.

Medolife Rx Announces Donation of Escozine to Heath Clinic in Dominican Republic for Use on Growing COVID-19 Positive Patient Population

Retrieved on: 
Wednesday, July 14, 2021

The Companys submission seeks approval for Escozine as an effective palliative and/or therapeutic for the treatment of COVID-19.

Key Points: 
  • The Companys submission seeks approval for Escozine as an effective palliative and/or therapeutic for the treatment of COVID-19.
  • As many of our operations are in the DR, we want to remain good community partners and we believe this donation is an illustration of that commitment.
  • We would like to thank Dr. Mikaelian and the whole Medolife team for this extremely generous donation to our foundation, said Dr. Cruz Jiminian.
  • Escozine, which is comprised of scorpion peptides that have been polarized by the Companys proprietary process, is Medolifes lead drug candidate.

Uber Announces Date of Second Quarter 2021 Results Conference Call

Retrieved on: 
Tuesday, July 13, 2021

Uber Technologies, Inc. (NYSE: UBER) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Wednesday, August 4, 2021 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

Key Points: 
  • Uber Technologies, Inc. (NYSE: UBER) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Wednesday, August 4, 2021 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
  • A live webcast of the conference call and earnings release materials can be found on Ubers Investor Relations website at investor.uber.com .
  • A replay of the conference call will be accessible for at least 90 days.
  • Accordingly, investors should monitor the companys Investor Relations website, in addition to following the companys press releases, SEC filings, public conference calls, presentations, and webcasts.

Proactive news headlines including Golden Rim Resources, Ora Banda Mining, Nexus Minerals and ioneer

Retrieved on: 
Tuesday, July 13, 2021

Click here

Key Points: 
  • Click here
    Golden Rim Resources Ltd (ASX:GMR) continues to confirm multiple, broad, sub-parallel zones of gold mineralisation at its Kada Gold Project within Guineas Newmont gold resource area.
  • Click here
    Ora Banda Mining Ltd (ASX:OBM) (FRA:M6N) directors have demonstrated their confidence in the companys gold strategy by participating in the companys share purchase plan (SPP) announced on June 8.
  • Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th

Retrieved on: 
Tuesday, July 13, 2021

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (Adamis or the Company) today urged its valued stockholders to vote to reelect all five members of the Companys Board of Directors (the Board) at the upcoming Annual Meeting of Stockholders (the Annual Meeting) on July 16, 2021.

Key Points: 
  • Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (Adamis or the Company) today urged its valued stockholders to vote to reelect all five members of the Companys Board of Directors (the Board) at the upcoming Annual Meeting of Stockholders (the Annual Meeting) on July 16, 2021.
  • In addition, the Board issued the following statement:
    Ahead of this years Annual Meeting, the Board prioritized engaging with stockholders and gathering feedback regarding the Companys governance, operational priorities and overall strategy.
  • We very much appreciate that a large cross-section of stockholders ultimately provided their candid viewpoints to us and our representatives.
  • For more information about the Companys strategic priorities and high-potential pipeline, please view our updated investor presentation here .

Cactus Announces Timing of Second Quarter 2021 Earnings Release and Conference Call

Retrieved on: 
Monday, July 12, 2021

Cactus, Inc. (NYSE: WHD) (Cactus or the Company) today announced that it will issue its second quarter 2021 earnings release after market close on Wednesday, July 28, 2021.

Key Points: 
  • Cactus, Inc. (NYSE: WHD) (Cactus or the Company) today announced that it will issue its second quarter 2021 earnings release after market close on Wednesday, July 28, 2021.
  • The Company will host a conference call to discuss financial and operational results on Thursday, July 29, 2021 at 9:00 a.m. Central Time (10:00 a.m. Eastern Time).
  • The call will be webcast on Cactus website at www.CactusWHD.com .
  • An archived webcast of the conference call will be available on the Companys website shortly after the end of the call.

Acutus Medical Reports Preliminary Unaudited Second Quarter 2021 Financial Results

Retrieved on: 
Monday, July 12, 2021

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited results for the second quarter of 2021.

Key Points: 
  • CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited results for the second quarter of 2021.
  • Second quarter 2021 net sales are expected to be in the range of $4.6 to $4.7 million, reflecting growth of over 300% as compared to the prior years second quarter results and growth of approximately 30% as compared to the result from the first quarter of 2021.
  • The preliminary consolidated financial results presented above are not a comprehensive statement of the Companys financial results for the quarter ended June 30, 2021 and have not been audited, reviewed or compiled by our independent registered public accounting firm, KPMG LLP.
  • The preliminary consolidated financial results presented above are subject to the completion of the Companys financial closing procedures.

PROS Holdings, Inc. Announces Date of Second Quarter 2021 Financial Results Release, Conference Call, and Webcast

Retrieved on: 
Monday, July 12, 2021

PROS (NYSE: PRO), a provider of AI-powered solutions that optimize selling in the digital economy, will release its financial results for the second quarter ended June 30, 2021 after the U.S. financial markets close on Tuesday, August 3, 2021.

Key Points: 
  • PROS (NYSE: PRO), a provider of AI-powered solutions that optimize selling in the digital economy, will release its financial results for the second quarter ended June 30, 2021 after the U.S. financial markets close on Tuesday, August 3, 2021.
  • PROS Holdings, Inc. will host a conference call on Tuesday, August 3, 2021 at 4:45 p.m. EDT to discuss the companys financial results and business outlook.
  • The live and archived webcasts of this call can be accessed under the Investor Relations section of the Companys website at www.pros.com .
  • A telephone replay will be available until Tuesday August 17, 2021 at 1-844-512-2921 (toll-free) or 1-412-317-6671 using the pass code 13720942.

NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021

Retrieved on: 
Monday, July 12, 2021

Disclaimer on forward-looking information and risk factors:

Key Points: 
  • Disclaimer on forward-looking information and risk factors:
    This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995.The use of certain words, including believe, potential, expect and will and similar expressions, is intended to identify forward-looking statements.
  • Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated.
  • These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Companys commercialization efforts, the Companys continued ability to raise capital to fund its development and the overall impact of the COVID-19 outbreak on the global healthcare system as well as the Companys business, financial condition and results of operations.
  • This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.